Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Time to Thrombocytic Inhibition After Supine and Upright Ingestion of Efient

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Jacob Antonsen, Rigshospitalet, Denmark
ClinicalTrials.gov Identifier:
NCT01365741
First received: December 21, 2010
Last updated: April 9, 2016
Last verified: April 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2016
  Primary Completion Date: March 2016 (Final data collection date for primary outcome measure)